These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28986092)

  • 1. Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage.
    Brotherton JML; Bloem PN
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():42-58. PubMed ID: 28986092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccines versus cervical cancer screening.
    Stanley M
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):388-94. PubMed ID: 18538554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.
    Rambout L; Hopkins L; Hutton B; Fergusson D
    CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.
    Castellsagué X; Schneider A; Kaufmann AM; Bosch FX
    Gynecol Oncol; 2009 Dec; 115(3 Suppl):S15-23. PubMed ID: 19819540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance.
    Xu XX; Zhou JS; Yuan SH; Yu H; Lou HM
    Int J Environ Res Public Health; 2015 Sep; 12(9):10794-805. PubMed ID: 26404339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.
    Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G
    Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
    Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
    Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic HPV vaccines.
    Hancock G; Hellner K; Dorrell L
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():59-72. PubMed ID: 29108943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV vaccination for the prevention of cervical intraepithelial neoplasia.
    Kahn JA
    N Engl J Med; 2009 Jul; 361(3):271-8. PubMed ID: 19605832
    [No Abstract]   [Full Text] [Related]  

  • 12. AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
    McKeage K; Romanowski B
    Drugs; 2011 Mar; 71(4):465-88. PubMed ID: 21395359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer.
    Tjalma WA; Arbyn M; Paavonen J; van Waes TR; Bogers JJ
    Int J Gynecol Cancer; 2004; 14(5):751-61. PubMed ID: 15361181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV vaccines - A review of the first decade.
    Harper DM; DeMars LR
    Gynecol Oncol; 2017 Jul; 146(1):196-204. PubMed ID: 28442134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
    El-Zein M; Richardson L; Franco EL
    J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
    Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
    J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What should be known for the introduction of an HPV vaccine?].
    Muñoz N; Jacquard AC
    Presse Med; 2008 Oct; 37(10):1377-90. PubMed ID: 18786806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
    van de Laar RLO; Hofhuis W; Duijnhoven RG; Polinder S; Melchers WJG; van Kemenade FJ; Bekkers RLM; Van Beekhuizen HJ
    BMC Cancer; 2020 Jun; 20(1):539. PubMed ID: 32517663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom.
    Van Effelterre TP; Hogea C; Taylor SM
    Hum Vaccin Immunother; 2016; 12(1):8-19. PubMed ID: 26090944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.